Navigation Links
Satori Pharmaceuticals Adds Key Senior Members to its Leadership Team
Date:4/26/2010

r neuroscience research leader at Pfizer; Dr. Kevin Pojasek, Executive Director of Development, former head of Development at Solace Pharmaceuticals; and Dr. Barbara Tate, Vice President of Biology, recently a Research Fellow and Senior Director of neuroscience biology at Pfizer.

Alzheimer's disease is a debilitating disorder characterized by the progressive loss of memory, thought and language.  More than 5.2 million people in the US alone suffer from Alzheimer's disease and it is estimated that this form of dementia strikes more than 1 in 8 adults in the US over the age of 65 years.  By 2050, it is estimated that the number of new cases each year will double in the US to greater than 959,000.  Available therapies provide only temporary symptomatic relief.

About Satori™ Pharmaceuticals

Satori Pharmaceuticals is committed to the development of disease modifying therapies for Alzheimer's disease through innovative approaches that selectively target the key neurotoxic mediators and pathways of this debilitating neurodegenerative disorder.

Satori (www.satoripharma.com) was founded in 2005 by Dr. Mark Findeis and PureTech Ventures and is guided by a world renowned group of advisors including Dennis Selkoe, M.D., the Vincent and Stella Coates Professor of Neurologic Diseases at the Brigham and Women's Hospital, an affiliate of Harvard Medical School; Donald Price, M.D., Professor of Pathology, Neurology, and Neurosci
'/>"/>

SOURCE Satori Pharmaceuticals Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 Following the reintroduction of the ... (LAC) released a report today urging policymakers to ... heroin epidemic through more effective use of medication-assisted ... Case for Expanding Access to Medication-Assisted Treatment to ... health, justice, and economic advantages of medication-assisted treatment ...
(Date:3/4/2015)... FRAMINGHAM, Mass. , March 4, 2015   ... a leading innovator of less invasive, miniaturized circulatory support ... failure, today announced that CEO Doug Godshall ... Healthcare Conference at 8:00 a.m. Eastern Time on Tuesday, ... 10-12 at the Loews Miami Beach Hotel in ...
(Date:3/4/2015)... Mar. 04, 2015 Research and Markets ... of the "Negative Pressure Wound Therapy Market ... Industry Analysis, Size, Share, Growth, Trends and Forecast ... , The global negative pressure ... and by geography. By product types the NPWT ...
Breaking Medicine Technology:Improved Medication-Assisted Treatment Policy Could Aid Epidemic of 20 Million Americans with Untreated Addiction 2HeartWare Presentation At The 2015 Barclays Global Healthcare Conference To Be Webcast 2Global Negative Pressure Wound Therapy (Conventional and Single Use NPWT Systems) Market Report 2014-2020 2
... Utilization of the FDA cleared Axxent® Electronic Brachytherapy, eBx™, ... experience demonstrates the isotope-free cancer treatment platform is a patient and ... applications at the 11th Annual Meeting of the American Society of ... , , ...
... , April 28 Amicus Therapeutics (Nasdaq: FOLD ) will ... on Thursday, May 6, 2010 . The results announcement will be followed ... EDT . , , , ... investors may access the conference call at 5 p.m. EDT by ...
Cached Medicine Technology:12 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting 212 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting 312 Month Follow-Up Data for Isotope-Free Breast IORT Presented at ASBS Meeting 4Amicus Therapeutics to Host its First Quarter 2010 Financial Results Conference Call and Webcast on May 6, 2010 2
(Date:3/4/2015)... (PRWEB) March 04, 2015 The Conrad ... a total of $6.9 million, which will help ... Niger and Burkina Faso. , The programs cover three ... first will focus on fixing water points in disrepair, ... of local people to maintain water points and ensuring ...
(Date:3/4/2015)... March 04, 2015 Nike Swim Camps ... staff whose mission is to stimulate a love of ... Swim Camps provide campers the opportunity to train with ... says Paul Merrion, Vice President of US Sports Camps. ... each swimmer to build confidence and improve their technique.” ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Nitrosigine®, a ... ingredient in premium sports nutrition products, is hosting the ... booth in the Terrace Ballroom at The Arnold Sports ... March 5, 2015 to March 8, 2015. , ... with FDA New Dietary Ingredient notification status; now affirmed ...
(Date:3/4/2015)... The report “Vasculitis – Pipeline Review, ... for Vasculitis. Vasculitis is a disease that features tenderness ... diseases is not known. Vasculitis can affect any body ... Symptoms can include fever, weight loss, tiredness, aches, pains, ... a limb. Vasculitis is treatable, but it is not ...
(Date:3/4/2015)... The week of March 2nd - ... Sleep Awareness Day being recognized on March 13th, the ... financial risks associated with sleep related illnesses, costing the ... Centers of America have turned to social media with ... will virally inspire conversation regarding the disease. , ...
Breaking Medicine News(10 mins):Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 3Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 4
... Just in time for National Folic Acid Awareness Week ... Rice Federation has teamed up with the National Council ... about the importance of folic acid for good health, ... their intake, such as consuming enriched rice.Research shows that ...
... Leventhal Consulting, www.leventhalconsulting.net , a high-end consulting ... opened today in Washington, DC. Leventhal Consulting ... clients over the phone, through e-mail, and in ... Consulting consists of four elements: (a) Customized ...
... Jan. 5 The National Federation of the Blind ... in the United States, in partnership with the Sendero ... (CES), held January 6-11, 2009, in Las Vegas. ... will feature a booth sponsored by the National Federation ...
... OAKLAND, Calif., Jan. 5 Kaiser Permanente announced today,that it ... years,to sponsor the IHI Open School for Health Professions, an ... Funding for the new IHI Open School demonstrates Kaiser ... health care. , "I am proud ...
... 5 Clarus Ventures, LLC ("Clarus Ventures"), a leading ... of Edward Scolnick, M.D., as a Venture Partner and ... Firm,s Cambridge, Mass. office."Both Drs. Scolnick and Kuruvilla have ... and technology," said Nick Galakatos, Ph.D., a Managing Director ...
... - This is a reissue of a previously killed ... to use the contents of this,release. , ... ) is encouraging all parents who decide,to give up smoking ... they will save towards their children,s futures. , ...
Cached Medicine News:Health News:USA Rice Federation Partners with National Council on Folic Acid to Promote National Folic Acid Awareness Week 2Health News:USA Rice Federation Partners with National Council on Folic Acid to Promote National Folic Acid Awareness Week 3Health News:Leventhal Consulting Opens for Business 2Health News:National Federation of the Blind to Exhibit at Consumer Electronics Show 2Health News:Kaiser Permanente Provides Seed Funding to the Institute for Healthcare Improvement's New Open School for Health Professions 2Health News:Kaiser Permanente Provides Seed Funding to the Institute for Healthcare Improvement's New Open School for Health Professions 3Health News:Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla 2Health News:Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla 3Health News:New Year Quitters Urged to Invest in Their Family's Futures 2
... is a reagent and probe system used ... high throughput plate based system is a ... a unique approach for RNA detection and ... branched DNA (bDNA) technology. Branched DNA allows ...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
For the qualitative detection of Wuchereria bancrofti antigen in whole blood, serum and plasma specimens...
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
Medicine Products: